CVE-2016-8358

Description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.

Category

8.5
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.15%
Third-Party Advisory securityfocus.com Third-Party Advisory us-cert.gov
Affected: n/a Smiths-Medical CADD-Solis Medication Safety Software through 3.1
Published at:
Updated at:

References

Link Tags
https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 third party advisory us government resource
http://www.securityfocus.com/bid/94630 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2016-8358?
CVE-2016-8358 has been scored as a high severity vulnerability.
How to fix CVE-2016-8358?
To fix CVE-2016-8358, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2016-8358 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2016-8358 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2016-8358?
CVE-2016-8358 affects n/a Smiths-Medical CADD-Solis Medication Safety Software through 3.1.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.